Filing Details
- Accession Number:
- 0001123292-20-001279
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-18 17:35:31
- Reporting Period:
- 2020-12-16
- Accepted Time:
- 2020-12-18 17:35:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882104 | Pdl Biopharma Inc. | PDLI | Biological Products, (No Disgnostic Substances) (2836) | 943023969 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1029625 | A Edward Mule | Two Greenwich Plaza, First Floor Greenwich CT 06830 | No | No | Yes | No | |
1332784 | L.p. Capital Point Silver | Two Greenwich Plaza, First Floor Greenwich CT 06830 | No | No | Yes | No | |
1382617 | J Robert O'shea | Two Greenwich Plaza, First Floor Greenwich CT 06830 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-16 | 1,350,000 | $2.58 | 14,863,460 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-17 | 398,000 | $2.61 | 15,261,460 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |